Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lantheus Holdings (LNTH)

Lantheus Holdings (LNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Lantheus Holdings 201 BURLINGTON ROAD SOUTH BUILDING BEDFORD MA 01730 USA

www.lantheus.com Employees: 808 P: 978-671-8001 F: 978-671-8860

Sector:

Medical

Description:

Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations, radiopharmacies and wholesalers. Lantheus Holdings, Inc. is based in NORTH BILLERICA, United States.

Key Statistics

Overview:

Market Capitalization, $K 4,454,176
Enterprise Value, $K 4,107,616
Shares Outstanding, K 66,312
Float, K 65,317
% Float 98.50%
Short Interest, K 5,365
Short Float 8.09%
Days to Cover 5.46
Short Volume Ratio 0.63
% of Insider Shareholders 1.50%
% of Institutional Shareholders 99.06%

Financials:

Annual Sales, $ 1,534 M
Annual Net Income, $ 312,440 K
Last Quarter Sales, $ 384,010 K
Last Quarter Net Income, $ 27,770 K
EBIT, $ 347,530 K
EBITDA, $ 416,450 K

Growth:

1-Year Return -17.87%
3-Year Return 12.66%
5-Year Return 247.34%
5-Year Revenue Growth 341.62%
5-Year Earnings Growth 405.98%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.27 on 11/06/25
Next Earnings Date 02/25/26 [--]
Earnings Per Share ttm 4.95
EPS Growth vs. Prev Qtr -25.00%
EPS Growth vs. Prev Year -33.11%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

LNTH Ratios

Ratio
Price/Earnings ttm 13.17
Price/Earnings forward 13.91
Price/Earnings to Growth N/A
Return-on-Equity % 30.88%
Return-on-Assets % 16.63%
Profit Margin % 20.37%
Debt/Equity 0.51
Price/Sales 3.08
Price/Cash Flow 9.19
Price/Book 3.96
Book Value/Share 16.46
Interest Coverage 22.91
60-Month Beta -0.08
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar